SciVision Biotech Inc. (TPE:1786)

SciVision Biotech Revenue

SciVision Biotech had revenue of 211.03M TWD in the quarter ending June 30, 2026, with 0.73% growth. This brings the company's revenue in the last twelve months to 889.15M, down -0.23% year-over-year. In the year 2025, SciVision Biotech had annual revenue of 886.62M with 0.37% growth.

• Revenue (ttm): 889.15M
• Revenue Growth: -0.23%
• P/S Ratio: 4.17
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.71B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	886.62M	3.31M	0.37%
Dec 31, 2024	883.31M	170.32M	23.89%
Dec 31, 2023	712.99M	155.64M	27.93%
Dec 31, 2022	557.35M	51.81M	10.25%
Dec 31, 2021	505.54M	38.66M	8.28%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error